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Introduction In the first half of the 20th century, while the value of translating scientific discovery to clinical care was
clearly established, the pace of innovation was resulting in increased specialization in both medicine and science — and
increased duration of their respective training paths. In the 1950s and 1960s, American doctors were drafted to serve in
the Korean and Vietnam Wars (1). In 1953, the National Institutes of Health (NIH) started its Associate Training Program,
which selected physicians who applied to the US Public Health Service Commissioned Corps to serve as clinical
associates at the NIH (2). Associates were allowed to pursue mentored research training at the NIH and a unique
opportunity for physician-scientist training emerged (3). In 1956, the NIH launched its Experimental Training Program to
provide medical students with opportunities for summer research experiences or additional years of training focused on
research (4). Such programs have produced leading scientists, including several Nobel Prize laureates, members of the
National Academy of Sciences, and directors and institute directors at the NIH (1). Individual medical schools began
offering combined MD-PhD training in the 1950s, and in 1964, the National Institute of General Medical Sciences
(NIGMS) launched the Medical Scientist Training Program (MSTP) to facilitate MD-PhD dual-degree training programs
(4). MSTP graduates are well represented in academia (4); yet, they comprise […]
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Introduction

In the first half of the 20th century, while
the value of translating scientific discovery to clinical care was clearly established,
the pace of innovation was resulting in
increased specialization in both medicine
and science — and increased duration
of their respective training paths. In the
1950s and 1960s, American doctors were
drafted to serve in the Korean and Vietnam
Wars (1). In 1953, the National Institutes of
Health (NIH) started its Associate Training Program, which selected physicians
who applied to the US Public Health Service Commissioned Corps to serve as clinical associates at the NIH (2). Associates

were allowed to pursue mentored research
training at the NIH and a unique opportunity for physician-scientist training
emerged (3). In 1956, the NIH launched its
Experimental Training Program to provide
medical students with opportunities for
summer research experiences or additional years of training focused on research
(4). Such programs have produced leading
scientists, including several Nobel Prize
laureates, members of the National Academy of Sciences, and directors and institute
directors at the NIH (1).
Individual medical schools began
offering combined MD-PhD training
in the 1950s, and in 1964, the Nation-
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al Institute of General Medical Sciences
(NIGMS) launched the Medical Scientist
Training Program (MSTP) to facilitate
MD-PhD dual-degree training programs
(4). MSTP graduates are well represented in academia (4); yet, they comprise a
small pool of talent and the total number of physicians engaged in research in
the United States continues to diminish.
While 41,178 research doctorate degrees
were conferred in science and engineering fields in the United States in 2016 (5),
only about 600 dual-degree MD-PhD
students are graduated annually (6). The
much larger pool of MD-only graduates
(approximately 20,000 annually) therefore represents untapped potential to substantially increase the number of physicians engaged in research. However, most
US MD programs focus on clinical training
without a research component.
Accordingly, the Burroughs Wellcome
Fund (BWF) launched an initiative in
2017 to develop a new cadre of MD-only
physician-scientists by addressing barriers particular to them. The BWF Physician-Scientist Training Initiative infused
$25 million in flexible Physician-Scientist
Institutional Awards (PSIAs), granted to
ten medical schools who proposed innovative approaches to MD-only physicianscientist development. For the purposes
of this initiative, “physician-scientist” is
defined as a medical student or physician
(MD, DO, or equivalent) actively engaged
in laboratory-based discovery science.
1
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The BWF identified several common
barriers to physician-scientist training: (a)
lack of mentoring/role models, (b) lack of
structured research training/experience
in discovery science, (c) financial pressures and debt, (d) limited administrative
support/centralized structure for physician-scientist training pathways, (e) burden of clinical training/responsibilities,
and (f) career–personal life balance (7).
Based on institutional support, commitment to diversity, scalability, and longitudinal evaluation plan, BWF awarded PSIA
grants to ten institutions: Duke University
(8), Stanford University (9), University of
Pittsburgh (10), University of Texas Southwestern Medical Center (11), Vanderbilt
University (12), Texas A&M University
(13), UCLA (14), University of Chicago
(15), Washington University (16), and Weill
Cornell Medicine (17). The five-year, $2.5
million grants support development, testing, evaluating, disseminating, and sustaining novel approaches that address the
barriers to physician-scientist training,
with the ultimate goal of developing a new
generation of physician-scientists who
advance biomedical discovery to improve
human health.

Description and administration
of programs

Summary and categories of institutional
approaches. PSIA institutions have implemented their programs (Figure 1) , featuring many common elements. Individual
approaches include structured education/
training/professional development; funding opportunities (for research support,
tuition, or personal life use); integrated
research training programs; mentorship;
and new degree and certificate programs.
Many programs feature distinctive elements, including networking and community building, connections with regional
experts and infrastructure, and leadership
training. Collectively, PSIA programs
serve medical students, residents, fellows,
instructors, and early-career faculty — with
some targeting a single vulnerable group
and others addressing the entire pipeline.
Institutional support. Institutional support provides avenues for sustainability of
effective approaches. All PSIA grantees
indicated institutional matching funds and
leveraging/consolidation of preexisting
programs for more centralized institution2

al approaches to supporting physician-scientist development. Institutional support
includes funds provided by schools and
health systems, Deans’ offices, and departments; administrative (staff and faculty
leadership) support; funding for specific
programmatic activities; philanthropic
gifts; and commitments to sustain support
at the conclusion of the funding period.
Diversity, equity, and inclusion. PSIA
grantees report dedication to serving
diverse constituencies and addressing
the systemic racism that has perpetuated underrepresentation and inequity.
All programs are collecting participant
demographic information. Most are also
collecting information on disability and
disadvantaged-background status. At this
early time point, one-third of PSIA programs reported that less than 10% of their
participants were from racial and ethnic
populations underrepresented in medicine
(URiM) backgrounds, one-third reported
between 10% and 25%, and the remainder reported between 26% and 50% participants from URiM backgrounds. In
two-thirds of programs, women made up
51%–75% of participants, and one-third
reported that 25%–50% of their participants are female.
Approaches to enhance diversity,
equity, and inclusion have included workshops and trainings, formal integration of
diversity and inclusion leadership in program teams, and assessment of programmatic reach to URiM individuals. Because
individuals from URiM backgrounds and
women are poorly represented at senior
faculty and leadership levels, diversity
among potential mentors is limited. PSIA
grantees report leveraging peer and “nearpeer” mentorship for enhanced diversity
among role models, providing culturally
aware mentor training, and investing in
long-term strategies to increase diversity in the physician-scientist pipeline by
focusing on programs and activities that
provide early exposure to the career path.

Program implementation

All PSIA institutions established a new
administrative office or other structure
to coordinate programs, which included
hiring staff and establishing leadership
positions, securing mentors and research
preceptors, raising matching funds, developing evaluation and tracking tools; and

establishing effective communication
strategies for recruitment and promotion.
Implementation barriers. Programs
intending to offer preferred admission
to next-stage training (i.e., residency or
fellowship physician-scientist training
programs [PSTPs]) at times discovered
challenges with the match process that
precluded a strategic transition. Furthermore, programs found that Graduate
Medical Education policies or time and
resource constraints might limit support
of research-in-residency opportunities
for patient-oriented discovery science.
Practical challenges included limitations
in accessibility and quality of institutional data on students, trainees, and faculty
needed to identify the target audience for
PSIA initiatives; as well as the substantial
time required to organize infrastructure,
hire staff, and promote acceptance of programs by participants.
Lessons learned. To develop the resilience required to simultaneously master
medicine and science, camaraderie is
key. PSIA grantees have established mentorship teams, peer networks, advanced
career development content, and executive coaching to this end. Compensation
for mentor effort offers an approach to
incentivize participation. The provision
of financial and human resources (e.g.,
technician support) facilitates difficult
transitions between research and clinical
training. Vertical integration across the
physician-scientist community contributes to promoting program engagement,
visibility, and retention across training and
career transitions. Careful coordination
and communication with administrators
and regulatory and accreditation bodies
— and across existing programs and infrastructure — is necessary both to promote
buy-in and to navigate potential political
sensitivities or territoriality.
Institutional changes. All ten PSIA
grantees launched substantial organizational changes, with the development of
new centralized divisions or offices that
serve as “home” for physician-scientists;
new associate dean or other leadership
positions; and/or new curriculum, tracks,
or Master’s and certificate programs in
medical school training, residency, or fellowship programs.
National-level changes. Efforts and early outcomes of PSIA programs and projects
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Figure 1. PSIA-funded programs, approaches, and career stage targets. PSIA institutions completed a survey to catalog and compare categorical key
approaches across institutions as well as the targeted career stage by program. Key approaches were categorized and approaches newly launched with the
PSIA are indicated with black-filled circles. Those that were preexisting at an awardee institution, but incorporated into the PSIA program, are indicated
with gray-filled circles. Approaches that were preexisting and not incorporated into the PSIA program are indicated with open circles. Career stage targets
by program are indicated with blue-filled circles.

have begun to influence the landscape of
physician-scientist training at a national
level. For example, a new nonprofit organization, the Physician Scientist Support
Foundation, is working nationally to estab-

lish an MD-only program that supports
a gap year for research (18). Additionally,
the first Association of American Medical
Colleges Liaison Committee on Medical
Education–approved integrated medicine

and engineering curriculum has been
established at a PSIA institution, providing
a model for similar approaches. Buttressed
by their organizational infrastructures,
PSIA grantees have successfully compet-
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ed for a large share (7 of 21) of the NIH
Stimulating Access to Research in Residency R38 pilot awards granted to date. In
turn, several national medical boards have
approved an R38 pathway for research in
residency at multiple institutions.
Traditional metrics. PSIA grantees are
tracking the outcomes of program participants to gauge success. All grantees intend
to compare their program participants to
MD-PhD students, baseline, or nonparticipants and to follow metrics of scholarly
output (grant applications/success, publications/impact factors, presentations,
honors and awards, patents/licenses)
and career progression, as appropriate
for the stage of intervention. Additionally, all programs are tracking attendance/
enrollment, matriculation, attrition, and
demographics of participants. PSIA grantees also report plans to assess the level of
engagement of participants, satisfaction
with programs and mentors, and longterm career plans via survey instruments.
Nontraditional metrics. Individual PSIA
grantees have identified various plans to
track nontraditional metrics, including the
following validated tools: resilience/grit
scale, intrinsic/extrinsic motivation scale,
career adaptabilities scale, burnout scale,
and career/life satisfaction scale. Other unique metrics planned for evaluation
include surveys to assess perceived selfefficacy in research and mentoring relationships; and a survey tool called Diagnostic Assessment of Research Training
Strengths that will identify real and perceived barriers to MD-based research
careers at different stages of training; better
identify the personal training and mentoring needs of incoming trainees; and identify features of research training support that
may differ between men, women, and/or
individuals from URiM backgrounds.
Additional metrics will include
resource utilization and impact at different career stages; curriculum evaluation;
interdisciplinary faculty evaluation, trainee self-assessment, and peer assessment;
confidence in self-efficacy and research
efficacy; and personal identity essays. Surveys of mentors will identify challenges
of senior faculty and ways to incentivize
mentoring. For PSIA grantees focused
on medical students, a unique metric will
be to track those who enter a residency
program at another PSIA institution. Pro4

grams will evaluate their sustainability,
the number of physician-scientists entering and remaining in the career path, and
research breakthroughs discovered by
MD-only physician-scientists.

Summary and anticipated
impact

Collectively, the PSIA grantee institutions
are conducting ten different experiments.
Through these efforts, we aim to identify
and define key financial and nonfinancial
factors and resources needed to create a
longitudinally structured and continuous
immersive training path to professional
independence. Successful elements of the
ten PSIA experiments will broaden accessibility of the physician-scientist career
path to different clinical disciplines and
demographic populations. Establishment
of a national network of PSIA programs
and formalized relationships with other
institutions will continue multidisciplinary
support and mentorship for trainees,
with each serving as a hub for developing
expanded regional collaboratives for physician-scientist training.
Barriers to the successful pursuit of
MD-only research careers persist at institutional and national levels and must be
addressed in order to develop a critical
mass of physician-scientists in the biomedical workforce. The institutional classification of trainees during research years
may affect compensation and access to
low-cost health insurance. Institutions are
increasingly relying on clinical educator
faculty, resulting in limited interactions
for medical students with physician-scientists. Medical students are encouraged
to seek opportunities for higher quantities
of publications in order to compete for residency, dissuading their pursuit of discovery science experiences. At the national
level, the Accreditation Council for Graduate Medical Education (ACGME) requirements for quality improvement activities
during training have limited consideration
of laboratory-based research opportunities
among residents.
MD research opportunities can be
expanded through changes to medical
school curricula, summer research training opportunities, and postgraduate physician-scientist training programs that
integrate research and clinical training.
To support access to these opportunities,

it is critical that they not increase the substantial debt burden that faces medical
students. Collective investment by federal funding programs, institutions, health
systems, and philanthropy will be crucial
for successful execution of MD research
training programs.
We anticipate the PSIA efforts — combined with necessary policy changes at
the institutional and national levels — will
effectively lower the hurdles to establishing academic careers and ultimately
change the view of medical school, residency, and fellowship to an environment that supports generating physicianscientists throughout the career pipeline.
In turn, this investment will increase the
number of physician-scientists leading
successful research careers.
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